Novavax, Inc. (NVAX)
4.21  -0.14 (-3.22%)  11-12 12:09
Open: 4.63
High: 4.63
Low: 4.26
Volume: 634,868
Ask: 0 x 0
Bid: 0 x 0
Market Cap: 101M
PE Ratio: -0.59
Exchange: Nasdaq Global Select
Industry: Biotechnology
Sector: Healthcare
Technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell buy
Resistance 2: 4.88
Resistance 1: 4.58
Pivot price: 4.42
Support 1: 4.10
Support 2: 3.41
52w High: 51.6
52w Low: 4.01
MSFT147.4251.315 (0.9%)
TWTR29.16-0.18 (-0.61%)
BAC33.180 (0%)
AMZN1779.788.13 (0.46%)
FB194.234.62 (2.44%)
GM0 (0%)

Novavax Inc is a clinical-stage vaccine company. It is engaged in the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.

Zoom in Zoom out
Draw lines
Horizontal lines
Parallel lines
Fibonacci lines
Remove studies
Shot and share
EPS -6.870
Book Value -7.440
PEG Ratio 0.00
Gross Profit -5.832
Profit Margin (%) 0.00
Operating Margin (%) -922.83
Return on Assets (ttm) -44.4
Return on Equity (ttm) 0.0
Share on Facebook Tweet this page Share on google plus

Foxchart international: United States Canada United Kingdom Australia New Zealand Singapore India

© All Rights Reserved. | United States NYSE NASDAQ AMEX stock markets, stock quotes and stock technical analysis charts. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX